Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome

Author:

Palomba Stefano1,Falbo Angela1,Russo Tiziana1,Manguso Francesco2,Tolino Achille3,Zullo Fulvio1,De Feo Pierpaolo4,Orio Francesco5

Affiliation:

1. Department of Obstetrics and Gynecology (S.P., A.F., T.R., F.Z.), University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy

2. Departments of Clinical and Experimental Medicine (F.M.), University “Federico II” of Naples, 80131 Naples, Italy

3. Departments of Obstetrics and Gynecology (A.T.), University “Federico II” of Naples, 80131 Naples, Italy

4. Department of Internal Medicine (P.D.F.), Section of Internal Medicine and Metabolic and Endocrine Diseases, University of Perugia, 06100 Perugia, Italy

5. Departments of Endocrinology (F.O.), University “Parthenope” of Naples, 80133 Naples, Italy

Abstract

Abstract Context: To date, the metabolic effects of the long-term metformin administration in anovulatory patients with polycystic ovary syndrome (PCOS) are known, whereas few data are available on the effects of its suspension. Objective: The objective of the study was to evaluate the effects of metformin suspension on insulin sensitivity in PCOS patients. Design: This was a prospective, randomized, placebo-controlled study. Setting: The study was conducted at the University “Magna Graecia” of Catanzaro, Italy. Patients: Patients included 30 normal-weight anovulatory PCOS women and 10 age- and body mass index-matched healthy controls. Intervention: PCOS patients were randomized to receive 1700 mg daily metformin (metformin group) or placebo tables (placebo group) for 12 months, whereas no treatment was administered in healthy women (control group). Main Outcome Measures: Clinical, endocrine, and metabolic profile and clamp insulin sensitivity index were evaluated at study entry and after 6, 12, 18, and 24 months. Results: At baseline, the clamp insulin sensitivity index resulted significantly different (P < 0.05) in PCOS patients in comparison with healthy controls, without difference between metformin and placebo groups. During treatment, the clamp insulin sensitivity index was significantly improved (P < 0.05) in the metformin group in comparison with baseline and placebo group, without significant differences between the 6- and 12-month assessments. At 6 and 12 months after treatment suspension, in the metformin group, insulin sensitivity index significantly (P < 0.05) worsened in comparison with that observed at baseline and during treatment and with that observed in the placebo and control groups. Conclusion: In normal-weight anovulatory PCOS patients, long-term metformin administration exerts beneficial effects on peripheral insulin sensitivity. Furthermore, this effect disappears at treatment suspension.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.;Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group,2004

2. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus;Dunaif;Am J Med,1995

3. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters.;Carmina;J Clin Endocrinol Metab,2005

4. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.;Legro;J Clin Endocrinol Metab,1999

5. Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone.;Legro;J Clin Endocrinol Metab,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3